Results 51 to 60 of about 153,923 (257)
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Introduction Access to smoking cessation treatment is limited in many countries. Digital tools could support healthcare professionals (HCPs) who have limited training and resources to deliver evidence-based cessation treatment to patients.
Aleksandra Herbeć +2 more
doaj +1 more source
Behavioural interventions for tobacco cessation in India: A systematic review and meta-analysis
Tobacco consumption is an area of public health concern in India. One of the unmet needs of many low-resource countries is to provide cost-effective tobacco cessation interventions for reducing tobacco-related mortality.
Vandita Pahwa +5 more
doaj +1 more source
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
A Mobile App to Aid Smoking Cessation: Preliminary Evaluation of SmokeFree28 [PDF]
Background: Little is known about the effectiveness of mobile apps in aiding smoking cessation or their validity for automated collection of data on smoking cessation outcomes.
Kotz, D. +9 more
core +1 more source
Introduction Aim: Smoking relapse is a frequent phenomenon, in which depressive symptoms, cigarette dependence, and craving play a significant role. Previous studies have shown that people with depressive symptoms have greater cigarette dependence and ...
Carmela Martinez-Vispo +4 more
doaj +1 more source
Contemporary Smoking Cessation [PDF]
Background Tobacco smoking is the single most preventable cause of death in the United States today. Oncologists are in a unique position to affect the health and economic burdens of smoking by encouraging cessation among their patients who smoke. Methods
J L, Westmaas, V, Nath, T H, Brandon
openaire +2 more sources
The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad +2 more
wiley +1 more source
Factors associated with abstinence after a recent smoking cessation attempt across 28 European Union member states [PDF]
Introduction: There is a lack of information regarding factors associated with successful smoking cessation on a population and European Union (EU)-wide level.
Cheung, Chung-Mei M +8 more
core +1 more source
Metabolic Changes Following Smoking Cessation in Patients with Type 2 Diabetes Mellitus
Background: Smoking cessation is crucial for reducing complications of type 2 diabetes mellitus (T2DM), but associated weight gain can worsen glycemic control, discouraging quitting attempts.
Stamatina Driva +8 more
doaj +1 more source

